PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness

Mohamed Hamyeh1, Florence Bernex1,2, Romain M Larive1

  • 1IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, F-34298, France.

Theranostics
|January 16, 2020
PubMed

Insights

The protein tyrosine phosphatase PTPN13 inhibits breast tumor invasiveness by stabilizing cell adhesion and promoting desmosome formation. Loss of PTPN13 phosphatase activity increases tumor growth and aggressiveness, highlighting its tumor suppressor role.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cell biology

Background:

  • Protein tyrosine phosphatase PTPN13 (PTPN13) is suggested to have anti-oncogenic effects.
  • The precise role of PTPN13 in tumorigenesis is unclear due to its complex interaction with FAS receptor-induced apoptosis.

Purpose of the Study:

  • To elucidate the exact role of PTPN13 in breast tumor development and aggressiveness.
  • To determine the molecular mechanisms underlying PTPN13's tumor suppressor activity.

Main Methods:

  • Crossed transgenic mice lacking PTPN13 phosphatase activity with HER2-overexpressing mice.
  • Developed isogenic MDA-MB-231 breast cancer cell lines overexpressing wild-type or inactive PTPN13.
  • Conducted phosphoproteomic, gene ontology, wound healing, Boyden chamber, videomicroscopy, cell aggregation, and immunofluorescence assays.

Main Results:

  • Deletion of PTPN13 phosphatase activity significantly increased breast tumor development, growth, and invasiveness.
  • PTPN13 phosphatase activity is essential for inhibiting cell motility and invasion in MDA-MB-231 cells.
  • PTPN13 stabilizes intercellular adhesion and promotes desmosome formation, leading to a mesenchymal-to-epithelial transition phenotype in tumors.

Conclusions:

  • PTPN13 plays a crucial negative role in breast tumor invasiveness.
  • PTPN13's tumor suppressor function is mediated through the stabilization of cell junctions, particularly desmosomes.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K